Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    Open Studies | "Rheumatic Fever"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Rheumatic Fever" (8 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children
Condition: Rheumatic Fever
Intervention: Dietary Supplement: Streptococcus Salivarius BLIS K12
2 Recruiting Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
Condition: Rheumatic Diseases
Intervention:
3 Recruiting Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Scleroderma;   Spondylitis;   Gout;   Spinal Disease;   Chondrocalcinosis
Intervention:
4 Recruiting The Genetic Basis of Acquired Heart Disease in Africa
Conditions: Rheumatic Heart Disease;   Rheumatic Fever;   Endomyocardial Fibrosis;   Acquired Heart Disease
Intervention:
5 Not yet recruiting INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
Condition: Rheumatic Heart Disease
Interventions: Drug: Rivaroxaban (20 mg);   Drug: Vitamin K antagonists (VKA)
6 Not yet recruiting INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority
Condition: Rheumatic Heart Disease
Interventions: Drug: Rivaroxaban (15 mg);   Drug: Aspirin
7 Recruiting RhEumatiC Heart diseAse Genetics
Condition: Rheumatic Heart Disease
Intervention: Genetic: Next generation sequencing
8 Recruiting Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement
Conditions: Atrial Fibrillation;   Rheumatic Heart Disease
Interventions: Procedure: surgical prevention of atrial fibrillation;   Device: cardiomonitor

Study has passed its completion date and status has not been verified in more than two years.